Investors considering Monopar should keep a close eye out for announcements about further development of ALXN-1840. Any updates on its MNPR-101 line of oncology products, all of which are either in ...
It briefly surpassed 40 during the first week of January 2022, which was subsequently followed by a bear market. In 2022, the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all shed ...
Results that may be inaccessible to you are currently showing.